Treating osteoporosis to prevent fractures: current concepts and future developments
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Treating osteoporosis to prevent fractures: current concepts and future developments
Authors
Keywords
-
Journal
JOURNAL OF INTERNAL MEDICINE
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2019-01-18
DOI
10.1111/joim.12873
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Fracture incidence and secular trends between 1989 and 2013 in a population based cohort: The Rotterdam Study
- (2018) Katerina Trajanoska et al. BONE
- Romosozumab FRAME Study: A Post Hoc Analysis of the Role of Regional Background Fracture Risk on Nonvertebral Fracture Outcome
- (2018) Felicia Cosman et al. JOURNAL OF BONE AND MINERAL RESEARCH
- ACTIVExtend: 24 Months of Alendronate after 18 Months of Abaloparatide or Placebo for Postmenopausal Osteoporosis
- (2018) Henry G Bone et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Screening in the community to reduce fractures in older women (SCOOP): a randomised controlled trial
- (2018) Lee Shepstone et al. LANCET
- Effects of teriparatide and risedronate on new fractures in post-menopausal women with severe osteoporosis (VERO): a multicentre, double-blind, double-dummy, randomised controlled trial
- (2018) David L Kendler et al. LANCET
- Adverse effects of media reports on the treatment of osteoporosis
- (2018) Cristiana Cipriani et al. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
- Rates of osteoporosis screening and treatment following vertebral fracture
- (2018) David W. Barton et al. Spine Journal
- Fracture Prevention with Zoledronate in Older Women with Osteopenia
- (2018) Ian R. Reid et al. NEW ENGLAND JOURNAL OF MEDICINE
- Drug-Related Adverse Events of Osteoporosis Therapy
- (2017) Moin Khan et al. ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA
- Treatment Sequence Matters: Anabolic and Antiresorptive Therapy for Osteoporosis
- (2017) Felicia Cosman et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Vertebral Fractures After Discontinuation of Denosumab: A Post Hoc Analysis of the Randomized Placebo-Controlled FREEDOM Trial and Its Extension
- (2017) Steven R Cummings et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Response to Letter: Severe Rebound-Associated Vertebral Fractures After Denosumab Discontinuation
- (2017) Olivier Lamy et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Effects of teriparatide versus alendronate for treatment of postmenopausal osteoporosis
- (2017) Ya-Kang Wang et al. MEDICINE
- Romosozumab or Alendronate for Fracture Prevention in Women with Osteoporosis
- (2017) Kenneth G. Saag et al. NEW ENGLAND JOURNAL OF MEDICINE
- Vertebral fractures and their association with health-related quality of life, back pain and physical function in older women
- (2017) Lisa Johansson et al. OSTEOPOROSIS INTERNATIONAL
- Observations following discontinuation of long-term denosumab therapy
- (2017) M. R. McClung et al. OSTEOPOROSIS INTERNATIONAL
- Hip fracture trends in the United States, 2002 to 2015
- (2017) E. Michael Lewiecki et al. OSTEOPOROSIS INTERNATIONAL
- Osteoporosis treatment: recent developments and ongoing challenges
- (2017) Sundeep Khosla et al. Lancet Diabetes & Endocrinology
- 10 years of denosumab treatment in postmenopausal women with osteoporosis: results from the phase 3 randomised FREEDOM trial and open-label extension
- (2017) Henry G Bone et al. Lancet Diabetes & Endocrinology
- UK clinical guideline for the prevention and treatment of osteoporosis
- (2017) J. Compston et al. Archives of Osteoporosis
- Effect of Abaloparatide vs Placebo on New Vertebral Fractures in Postmenopausal Women With Osteoporosis
- (2016) Paul D. Miller et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Impact of the U.S. Food and Drug Administration's Safety-Related Announcements on the Use of Bisphosphonates After Hip Fracture
- (2016) Seoyoung C Kim et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Managing Osteoporosis in Patients on Long-Term Bisphosphonate Treatment: Report of a Task Force of the American Society for Bone and Mineral Research
- (2016) Robert A Adler et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Denosumab or Zoledronic Acid in Postmenopausal Women With Osteoporosis Previously Treated With Oral Bisphosphonates
- (2016) P. D. Miller et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Romosozumab Treatment in Postmenopausal Women with Osteoporosis
- (2016) Felicia Cosman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Postmenopausal Osteoporosis
- (2016) Dennis M. Black et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effectiveness of a minimal resource fracture liaison service
- (2016) K. F. Axelsson et al. OSTEOPOROSIS INTERNATIONAL
- Imminent risk of fracture after fracture
- (2016) H. Johansson et al. OSTEOPOROSIS INTERNATIONAL
- Risk of hip, subtrochanteric, and femoral shaft fractures among mid and long term users of alendronate: nationwide cohort and nested case-control study
- (2016) Bo Abrahamsen et al. BMJ-British Medical Journal
- Risk of hip, subtrochanteric, and femoral shaft fractures among mid and long term users of alendronate: nationwide cohort and nested case-control study
- (2016) Bo Abrahamsen et al. BMJ-British Medical Journal
- Effects of Abaloparatide, a Human Parathyroid Hormone-Related Peptide Analog, on Bone Mineral Density in Postmenopausal Women with Osteoporosis
- (2015) Benjamin Z. Leder et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Osteoporosis: the evolution of a diagnosis
- (2015) M. Lorentzon et al. JOURNAL OF INTERNAL MEDICINE
- Denosumab and teriparatide transitions in postmenopausal osteoporosis (the DATA-Switch study): extension of a randomised controlled trial
- (2015) Benjamin Z Leder et al. LANCET
- Teriparatide treatment patterns in osteoporosis and subsequent fracture events: a US claims analysis
- (2015) M. M. Bonafede et al. OSTEOPOROSIS INTERNATIONAL
- Osteonecrosis of the jaw (ONJ): diagnosis and management in 2015
- (2015) A. Khan et al. OSTEOPOROSIS INTERNATIONAL
- Comparative Effectiveness of Pharmacologic Treatments to Prevent Fractures
- (2014) Carolyn J. Crandall et al. ANNALS OF INTERNAL MEDICINE
- The Potential Economic Benefits of Improved Postfracture Care: A Cost-Effectiveness Analysis of a Fracture Liaison Service in the US Health-Care System
- (2014) Daniel H Solomon et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Osteoporosis Medication Use After Hip Fracture in U.S. Patients Between 2002 and 2011
- (2014) Daniel H Solomon et al. JOURNAL OF BONE AND MINERAL RESEARCH
- New bone-forming treatments for osteoporosis
- (2014) Socrates E. Papapoulos Nature Reviews Endocrinology
- Romosozumab in Postmenopausal Women with Low Bone Mineral Density
- (2014) Michael R. McClung et al. NEW ENGLAND JOURNAL OF MEDICINE
- Meta-analysis: Excess Mortality After Hip Fracture Among Older Women and Men
- (2013) Patrick Haentjens ANNALS OF INTERNAL MEDICINE
- Bisphosphonates and risk of subtrochanteric, femoral shaft, and atypical femur fracture: A systematic review and meta-analysis
- (2013) Lydia Gedmintas et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Atypical Subtrochanteric and Diaphyseal Femoral Fractures: Second Report of a Task Force of the American Society for Bone and Mineral Research
- (2013) Elizabeth Shane et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Reduction in the Risk of Clinical Fractures After a Single Dose of Zoledronic Acid 5 Milligrams
- (2013) I. R. Reid et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Diagnosis and management of osteoporosis in postmenopausal women and older men in the UK: National Osteoporosis Guideline Group (NOGG) update 2013
- (2013) J. Compston et al. MATURITAS
- Incidence and demography of femur fractures with and without atypical features
- (2012) Adrianne C Feldstein et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Incidence of atypical nontraumatic diaphyseal fractures of the femur
- (2012) Richard M Dell et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Update on Bone Anabolics in Osteoporosis Treatment: Rationale, Current Status, and Perspectives
- (2012) Roland Baron et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Models of care for the secondary prevention of osteoporotic fractures: a systematic review and meta-analysis
- (2012) K. Ganda et al. OSTEOPOROSIS INTERNATIONAL
- Patients with sclerosteosis and disease carriers: Human models of the effect of sclerostin on bone turnover
- (2011) Antoon H van Lierop et al. JOURNAL OF BONE AND MINERAL RESEARCH
- The effect of 3 versus 6 years of Zoledronic acid treatment of osteoporosis: A randomized extension to the HORIZON-Pivotal Fracture Trial (PFT)
- (2011) Dennis M Black et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Effects of Denosumab Treatment and Discontinuation on Bone Mineral Density and Bone Turnover Markers in Postmenopausal Women with Low Bone Mass
- (2011) Henry G. Bone et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Fracture liaison services for the evaluation and management of patients with osteoporotic fracture: a cost-effectiveness evaluation based on data collected over 8 years of service provision
- (2011) A. R. McLellan et al. OSTEOPOROSIS INTERNATIONAL
- Sclerostin: Current Knowledge and Future Perspectives
- (2010) M. J. C. Moester et al. CALCIFIED TISSUE INTERNATIONAL
- Skeletal disease in primary hyperparathyroidism
- (2010) Shonni J. Silverberg et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Single-dose, placebo-controlled, randomized study of AMG 785, a sclerostin monoclonal antibody
- (2010) Desmond Padhi et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Effects of Teriparatide, Alendronate, or Both in Women with Postmenopausal Osteoporosis
- (2010) Joel S. Finkelstein et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- FRAX® and its applications to clinical practice
- (2009) John A. Kanis et al. BONE
- Effects of Teriparatide Treatment and Discontinuation in Postmenopausal Women and Eugonadal Men with Osteoporosis
- (2009) Benjamin Z. Leder et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Denosumab for Prevention of Fractures in Postmenopausal Women with Osteoporosis
- (2009) Steven R. Cummings et al. NEW ENGLAND JOURNAL OF MEDICINE
- Clinical subsequent fractures cluster in time after first fractures
- (2008) T A C M van Geel et al. ANNALS OF THE RHEUMATIC DISEASES
- Denosumab, a Fully Human Monoclonal Antibody to RANKL, Inhibits Bone Resorption and Increases BMD in Knock-In Mice That Express Chimeric (Murine/Human) RANKL*
- (2008) Paul J Kostenuik et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Early Responsiveness of Women with Osteoporosis to Teriparatide After Therapy with Alendronate or Risedronate
- (2008) Paul D. Miller et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Mechanisms of action of bisphosphonates: similarities and differences and their potential influence on clinical efficacy
- (2008) R. G. G. Russell et al. OSTEOPOROSIS INTERNATIONAL
- Effects of Previous Antiresorptive Therapy on the Bone Mineral Density Response to Two Years of Teriparatide Treatment in Postmenopausal Women with Osteoporosis
- (2007) Steven Boonen et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started